Last reviewed · How we verify

The Central and Eastern European Gynecologic Oncology Group — Portfolio Competitive Intelligence Brief

The Central and Eastern European Gynecologic Oncology Group pipeline: 2 marketed, 0 filed, 2 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

2 marketed 0 filed 2 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

DrugGenericPhaseClassTargetAreaFirst approval
Antibiotics administration Antibiotics administration marketed Antibiotic (broad class) Infectious Disease / Supportive Care in Oncology
antibiotic prophylaxis antibiotic prophylaxis marketed Antibiotic (prophylactic) Infectious Disease Prevention / Surgical Prophylaxis
Antenatal steroids administration Antenatal steroids administration phase 3 Corticosteroid Glucocorticoid receptor Obstetrics/Neonatology
Neuroprotection Neuroprotection phase 3 Neuroscience

Therapeutic area mix

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

  1. AIDS Malignancy Consortium · 1 shared drug class
  2. ANI Pharmaceuticals · 1 shared drug class
  3. AbbVie · 1 shared drug class
  4. Acrotech Biopharma Inc. · 1 shared drug class
  5. Allergan · 1 shared drug class
  6. Aramis Biosciences, Inc. · 1 shared drug class
  7. Assistance Publique - Hôpitaux de Paris · 1 shared drug class
  8. · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for The Central and Eastern European Gynecologic Oncology Group:

Cite this brief

Drug Landscape (2026). The Central and Eastern European Gynecologic Oncology Group — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/the-central-and-eastern-european-gynecologic-oncology-group. Accessed 2026-05-17.

Related